Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Return on Assets (2018 - 2025)

Dianthus Therapeutics has reported Return on Assets over the past 7 years, most recently at 0.28% for Q3 2025.

  • Quarterly results put Return on Assets at 0.28% for Q3 2025, down 8.0% from a year ago — trailing twelve months through Sep 2025 was 0.28% (down 8.0% YoY), and the annual figure for FY2024 was 0.31%, up 3.0%.
  • Return on Assets for Q3 2025 was 0.28% at Dianthus Therapeutics, up from 0.34% in the prior quarter.
  • Over the last five years, Return on Assets for DNTH hit a ceiling of 0.07% in Q2 2023 and a floor of 0.34% in Q2 2025.
  • Median Return on Assets over the past 4 years was 0.23% (2024), compared with a mean of 0.2%.
  • Biggest five-year swings in Return on Assets: surged 39bps in 2023 and later fell -23bps in 2024.
  • Dianthus Therapeutics' Return on Assets stood at 0.17% in 2022, then plummeted by -40bps to 0.23% in 2023, then grew by 1bps to 0.23% in 2024, then fell by -22bps to 0.28% in 2025.
  • The last three reported values for Return on Assets were 0.28% (Q3 2025), 0.34% (Q2 2025), and 0.28% (Q1 2025) per Business Quant data.